IFF’s Philippe Horvath Inducted into The National Inventors Hall of Fame
Molecular biologist honored for contributions to science, enhancing global food supply and laying the foundation for gene editing
“IFF congratulates Philippe on this unique recognition,” said
Horvath’s initial article, published in Science in 2007, provided the first biological evidence that CRISPR-Cas constitutes an immunity system against viruses in bacteria. IFF scientists were among the first to understand how the CRISPR system works in bacteria. Beginning in the early 2000s, Horvath and colleagues initially utilized CRISPR for bacterial identification, then for its ability to improve the resistance of starter culture strains against bacteriophage attack. The discoveries opened new research avenues and laid the groundwork that inspired numerous scientists to pursue the CRISPR field.
“I am deeply honored to be selected by the
Based at IFF’s site in Dangé-Saint-Romain,
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet.Learn more at iff.com,
© 2022 by
View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005853/en/
Head of
332-877-5339
Media.request@iff.com
Director of Investor Relations
212-708-7263
Investor.Relations@iff.com
Source: IFF